Marta Bini

Head And Neck Medical Oncology Department
Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management.

Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management.

Journal: Therapeutic advances in medical oncology
Published: March 11, 2025

Bridging borders with care: a journey in providing oncology treatment to foreign women at a tertiary center in Italy.

Bridging borders with care: a journey in providing oncology treatment to foreign women at a tertiary center in Italy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 26, 2024

A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.

A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.

Journal: Cancers
Published: November 22, 2023

Empowering gynecologic oncologists: navigating new drugs and emerging toxicities.

Empowering gynecologic oncologists: navigating new drugs and emerging toxicities.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 21, 2023

ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases.

ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases.

Journal: JCO precision oncology
Published: August 10, 2023

High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.

High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 09, 2023

Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?

Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?

Journal: Cancer treatment reviews
Published: August 04, 2023

The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer.

The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer.

Journal: Journal of clinical medicine
Published: June 26, 2023

Treatments for rare ovarian tumors: What's new?

Treatments for rare ovarian tumors: What's new?

Journal: Bulletin du cancer
Published: January 13, 2023

Endometrial carcinosarcoma.

Endometrial carcinosarcoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 30, 2022

Update on new treatments for rare ovarian tumours.

Update on new treatments for rare ovarian tumours.

Journal: Current opinion in obstetrics & gynecology
Published: November 28, 2022

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world.

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world.

Journal: Frontiers in molecular biosciences
Published: July 17, 2022
Showing 1-12 of 25

Last Updated: 09/26/2026